Search for dissertations about: "cholesterol-lowering"
Showing result 1 - 5 of 35 swedish dissertations containing the word cholesterol-lowering.
-
1. Metabolites of Avena sativa with Blood Cholesterol Lowering Properties
Abstract : Cardiovascular diseases are among the most important causes of death in thedeveloped countries. These diseases are partly caused by too high cholesterolconcentrations in the blood. Avena sativa, oat, is the most common spieces of the genus Avena, and produced in huge amounts worldwide. READ MORE
-
2. Cholesterol-lowering and anti-atherogenic effects of oats in mice
Abstract : The cholesterol-lowering effect of oats is well established, but the crucial properties eliciting this effect need to be further investigated to optimize the use of oats as functional foods. Furthermore, there are almost no reports investigating the effect of oats on atherosclerosis development. READ MORE
-
3. Implications of cholesterol and cholesterol-lowering therapy in Alzheimer's disease
Abstract : BACKGROUND: Alzheimer's disease (AD) is a severe neurodegenerative disease that mainly afflicts elderly persons, with a characteristic progressive decline of cognitive functions and dementia. It is believed that the majority of all AD patients are affected by the sporadic form, thus caused by the combined effects of several risk factors, such as elevated cholesterol levels in midlife and deficiencies in the lipoprotein transporters apolipoprotein E (ApoE). READ MORE
-
4. Cholesterol-lowering properties of oats: Effects of processing and the role of oat components
Abstract : The cholesterol-lowering effect of oats has been studied for almost fifty years. The effect has hitherto essentially been associated with its content of β-glucans, the primary soluble dietary fibre in oats. READ MORE
-
5. Novel aspects of atherosclerosis : focusing on new target genes and the effect of cholesterol-lowering
Abstract : Atherosclerosis is most often the main underlying cause of cardiovascular diseases (CVDs), accounting for more than 31% of all deaths worldwide. It is driven by the uptake of low-density lipoproteins (LDL) by a dysfunctional arterial endothelium. READ MORE